Results 171 to 180 of about 337,814 (260)

Enhancing Stability of Metallic Magnesium Nanoparticles toward Oxidation in Water via PEG‐Phosphonate Passivation

open access: yesChemistry – A European Journal, EarlyView.
Metallic magnesium nanoparticles are stabilized against rapid oxidation in water through surface passivation with phosphonic acid–terminated poly(ethylene glycol). By controlling the timing of ligand addition during synthesis, nanoparticle growth, morphology, and aqueous lifetime are tuned, extending stability from minutes to hours while preserving ...
Anupong Nuekaew   +2 more
wiley   +1 more source

New Capital Rules According to Basel II [PDF]

open access: yesBanks and Bank Systems, 2007
Ivana Valová
doaj  

Biomarker‐Based Prediction of OATP1B1 Activity in Clinical Routine—Investigating Coproporphyrins as Markers for Drug–Drug–Gene Interactions

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
Coproporphyrin I (CPI) is an established endogenous biomarker for detecting drug–drug interactions (DDIs) involving the hepatic uptake transporter Organic Anion Transporting Polypeptide 1B1 (OATP1B1, gene SLCO1B1). While CPI has been extensively studied in healthy volunteers using controlled pre‐ and post‐OATP1B1‐inhibitor sampling, its applicability ...
Leila Potzel   +9 more
wiley   +1 more source

Basel Pillar II risks in Italian banks [PDF]

open access: yesBanks and Bank Systems, 2012
Federica Ielasi
doaj  

Digital Transformation of Medicines Regulation in Africa—Perspectives from a Stakeholder Convening

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
Regulatory authorities worldwide are developing strategies to integrate artificial intelligence (AI) into the lifecycle of health products, technologies, and medicines. While regulators share goals of improving efficiency, strengthening decision‐making, and protecting public health, their approaches differ according to institutional structures ...
Christelna Reyneke   +12 more
wiley   +1 more source

Comparative Dentoskeletal Effects of Two Fixed Systems in Treating Class II Malocclusion: A Retrospective Cohort Study. [PDF]

open access: yesHealthcare (Basel)
Lorusso M   +6 more
europepmc   +1 more source

Patient‐Centric First‐in‐Human Dose Selection: An Ex Vivo Minimal Anticipated Biological Effect Level Approach for T‐Cell Engagers in Multiple Myeloma

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
The minimal anticipated biological effect level (MABEL) approach to first‐in‐human (FIH) dose calculation can lead to long dose‐escalation periods before observing clinical activity. We used a novel ex vivo MABEL approach to calculate the FIH starting dose for forimtamig, a T‐cell bispecific antibody under investigation for the treatment of relapsed ...
Thomas E. Kraft   +16 more
wiley   +1 more source

Home - About - Disclaimer - Privacy